Vanguard Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Sell |
|
|||||
|
2025
Q1 | $5.18M | Sell |
|
|||||
|
2024
Q4 | $9.91M | Sell |
|
|||||
|
2024
Q3 | $17M | Sell |
|
|||||
|
2024
Q2 | $23.1M | Buy |
|
|||||
|
2024
Q1 | $69.3M | Sell |
|
|||||
|
2023
Q4 | $81.1M | Buy |
|
|||||
|
2023
Q3 | $105M | Buy |
|
|||||
|
2023
Q2 | $139M | Buy |
|
|||||
|
2023
Q1 | $72.9M | Buy |
|
|||||
|
2022
Q4 | $83.8M | Buy |
|
|||||
|
2022
Q3 | $88.9M | Sell |
|
|||||
|
2022
Q2 | $126M | Buy |
|
|||||
|
2022
Q1 | $150M | Buy |
|
|||||
|
2021
Q4 | $268M | Buy |
|
|||||
|
2021
Q3 | $209M | Buy |
|
|||||
|
2021
Q2 | $151M | Buy |
|
|||||
|
2021
Q1 | $105M | Buy |
|
|||||
|
2020
Q4 | $122M | Buy |
|
|||||
|
2020
Q3 | $37.1M | Buy |
|
|||||
|
2020
Q2 | $39.7M | Buy |
|